Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Report Date: July 24, 2003
Reporting Period: Second Quarter of 2003
This filing serves as a notification of the company's financial results for the second quarter of 2003, incorporating a press release issued on the same date as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K. It references the existence of financial results but does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that results for the second quarter of 2003 were reported.
Guidance, Outlook, and Risks
Regulation FD Disclosure: The filing includes information pursuant to Item 12 (Results of Operations and Financial Condition) and is presented under Item 9 (Regulation FD Disclosure) in accordance with SEC interim guidance (Release Nos. 33-8216 and 34-47583).
Legal Status: The information is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into any Securities Act registration statements.
Outlook/Risks: No specific guidance, management commentary, risks, or contingencies are detailed in the provided text.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached Press Release (Exhibit 99.1).
- Confirm the year-over-year growth rates for the second quarter of 2003.
- Review the full text of the press release for any updated forward-looking guidance or risk factors not summarized in this 8-K cover sheet.
- Check subsequent filings for any restatements or updates to the Q2 2003 results.